Research analysts at Lifesci Capital started coverage on shares of Veradermics (NYSE:MANE – Get Free Report) in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm set an “outperform” rating and a $135.00 price target on the stock. Lifesci Capital’s target price would indicate a potential upside of 43.95% from the company’s current price.
A number of other research firms have also recently commented on MANE. Wall Street Zen upgraded Veradermics from a “sell” rating to a “hold” rating in a research report on Sunday. Needham & Company LLC initiated coverage on shares of Veradermics in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $136.00 price target on the stock. Zacks Research raised shares of Veradermics to a “hold” rating in a research note on Tuesday, March 3rd. Citigroup raised their price target on shares of Veradermics from $120.00 to $135.00 and gave the company a “buy” rating in a research note on Monday, May 18th. Finally, Cantor Fitzgerald initiated coverage on shares of Veradermics in a research note on Monday, March 2nd. They issued an “overweight” rating on the stock. Six analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $114.20.
Read Our Latest Research Report on MANE
Veradermics Stock Down 2.6%
Veradermics (NYSE:MANE – Get Free Report) last posted its earnings results on Tuesday, May 12th. The company reported ($1.32) EPS for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.76).
Veradermics Company Profile
MANE is a global manufacturer and supplier of flavors, fragrances and ingredients for the food, beverage, personal care, household and fine fragrance markets. Headquartered in France, the company develops and produces aromatic solutions that are used by consumer goods companies, food processors, perfumers and formulators seeking sensory impact, taste modulation and olfactory character for their products.
The company’s product portfolio includes savory and sweet flavor systems, beverage concentrates, natural extracts, essential oils, fragrance compounds, cosmetic ingredients and specialty functional solutions such as taste enhancers and odor masking agents.
Recommended Stories
- Five stocks we like better than Veradermics
- 5 High-Yield Stocks With Analyst Support and Room to Run
- AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird Satellites
- Is Lennar Finally Turning the Corner After Its Housing Slump?
- AI Memory Demand Has Turned These 5 S&P 500 Stocks Into Market Leaders
Receive News & Ratings for Veradermics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradermics and related companies with MarketBeat.com's FREE daily email newsletter.
